Minkang Biological Group
Latest round
- Series B
Last raised
- Jul 2017
Total raised
- $5.9M
Investors
- 1
About Minkang Biological Group
Established in 2010 and based in Tianjin, China, Minkang Biological Group operates as a diabetes monitoring service provider dedicated to providing blood glucose monitors and other products. It has subsidiaries in Suzhou and Anhui. The company acquired certifications such as ISO9001 and CE certificate. In 2016, SY series blood glucose meters are officially on sale. The company mainly provides blood glucose monitor. It provides continuous glucose monitoring, blood sugar product series, blood lipid product series, blood ketone product series, uric acid product series, and myocardial infarction product series. The product covers multiple diabetes index tests such as blood sugar, glycosylated hemoglobin, uric acid, etc. Minkang Biological Group also provides insulin pen needles, medical surgical masks and other products. The company generates revenue by providing blood glucose monitor such as blood sugar product series, blood lipid product series, blood ketone product series, uric acid product series, and myocardial infarction product series.
Who invested in Minkang Biological Group
1 investor across 1 round
See all investors in Minkang Biological Group
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jul 1, 2017
Amount
$5.9M
Investors
Questions about Minkang Biological Group
Who invested in Minkang Biological Group?
Minkang Biological Group has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Minkang Biological Group raised?
Minkang Biological Group has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Minkang Biological Group last raise money?
Minkang Biological Group's most recent round on record is a Series B, in Jul 2017.
What does Minkang Biological Group do?
Established in 2010 and based in Tianjin, China, Minkang Biological Group operates as a diabetes monitoring service provider dedicated to providing blood glucose monitors and other products.
Where is Minkang Biological Group headquartered?
Minkang Biological Group is headquartered in Tianjin, China.
Which VCs invest in companies like Minkang Biological Group?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at Minkang Biological Group's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Minkang Biological Group? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.